Status:
COMPLETED
Study to Investigate the Analgesic Efficacy of a Single Dose of AZD1386
Lead Sponsor:
AstraZeneca
Conditions:
Pain
Eligibility:
All Genders
18-45 years
Phase:
PHASE2
Brief Summary
The primary aim of this study is to investigate if AZD1386 can relieve the pain induced by the surgical removal of one lower wisdom-tooth. This will be done by comparing the effect of AZD1386 to place...
Eligibility Criteria
Inclusion
- Patients scheduled for surgical removal of one partial or complete impacted mandibular third molar.
- Provision of signed informed consent.
Exclusion
- History of somatic disease/condition, which may interfere with the objectives for the study, as judged by the investigator.
- Clinically significant illness or clinically relevant trauma within the 2 weeks prior to the administration of the investigational product, as judged by the investigator.
- A family history of short QT syndrome (SQTS) or sudden cardiac death (SCD) amongst first degree relatives
- Patients with a body temperature \>37.5°C at Visit 2, before start of surgical procedures
Key Trial Info
Start Date :
April 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2008
Estimated Enrollment :
103 Patients enrolled
Trial Details
Trial ID
NCT00672646
Start Date
April 1 2008
End Date
June 1 2008
Last Update
June 8 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Salt Lake City, Utah, United States